This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_THYROICD2_ENDOCRINE_EXALLC for full statistics.
Carcinoma in situ, thyroid and other endocrine glands
CD2_INSITU_THYROICD2_ENDOCRINE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
11 |
4. Check minimum number of eventsNone |
11 |
5. Include endpointsNone |
11 |
6. Filter based on genotype QC (FinnGen only) |
11 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D09
- Name in latin
- Carcinoma in situ glandulae thyreoideae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ, thyroid and other endocrine glands
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ, thyroid and other endocrine glands
- Carcinoma in situ of other and unspecified sites
- Carcinoma in situ of other and unspecified sites
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 11 | 9 | - |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | - |
| Median age at first event (years) | 46.66 | 44.82 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_THYROICD2_ENDOCRINE – Carcinoma in situ, thyroid and other endocrine glands
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).